|
Volumn 346, Issue 8983, 1995, Pages 1157-1160
|
Impact of improved treatment of sexually transmitted disease on HIV infection
a,b,c,e,f,g a,b,c,e,f,g a,b,c,e,f,g a,b,c,e,f,g a,b,c,e,f,g a,b,c,e,f,g a,b,c,e,f,g a,b,c,e,f,g a,b,c,e,f,g a,b,c,e,f,g a,b,c,e,f,g a,b,c,e,f,g a,b,c,d,e,f,g a,b,c,e,f,g a,b,c,e,f,g a,b,c,e,f,g a,b,c,e,f,g a,b,c,e,f,g a,b,c,e,f,g a,b,c,e,f,g more.. |
Author keywords
[No Author keywords available]
|
Indexed keywords
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
NOTE;
RANDOMIZED CONTROLLED TRIAL;
SEXUALLY TRANSMITTED DISEASE;
TREATMENT OUTCOME;
DEVELOPING COUNTRY;
PREVALENCE;
RISK;
SERODIAGNOSIS;
CONDOM;
HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE;
LETTER;
PRIORITY JOURNAL;
PUBLIC HEALTH;
SEROCONVERSION;
SEXUAL BEHAVIOR;
HIV INFECTIONS;
HUMANS;
RANDOMIZED CONTROLLED TRIALS;
SEXUALLY TRANSMITTED DISEASES;
TREATMENT OUTCOME;
DEVELOPING COUNTRIES;
HIV SERONEGATIVITY;
HUMAN;
PREVALENCE;
RISK;
|
EID: 0028825184
PISSN: 01406736
EISSN: None
Source Type: Journal
DOI: 10.1016/S0140-6736(95)91830-2 Document Type: Letter |
Times cited : (9)
|
References (8)
|